As of 2025-07-19, the Relative Valuation of Rapt Therapeutics Inc (RAPT) is (97.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.68 USD, the upside of Rapt Therapeutics Inc based on Relative Valuation is -936.3%.
The range of the Relative Valuation is (74.75) - (136.24) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 18.5x | 13.0x |
| Forward P/E multiples | 10.1x - 21.0x | 13.5x |
| Fair Price | (74.75) - (136.24) | (97.68) |
| Upside | -740.0% - -1266.4% | -936.3% |
| Date | P/E |
| 2025-07-16 | -1.43 |
| 2025-07-15 | -1.44 |
| 2025-07-14 | -1.18 |
| 2025-07-11 | -1.15 |
| 2025-07-10 | -1.17 |
| 2025-07-09 | -1.14 |
| 2025-07-08 | -1.09 |
| 2025-07-07 | -1.11 |
| 2025-07-03 | -1.09 |
| 2025-07-02 | -1.09 |
| 2025-07-01 | -0.99 |
| 2025-06-30 | -1.09 |
| 2025-06-27 | -1.14 |
| 2025-06-26 | -1.32 |
| 2025-06-25 | -1.30 |
| 2025-06-24 | -1.11 |
| 2025-06-23 | -1.01 |
| 2025-06-20 | -1.01 |
| 2025-06-18 | -1.01 |
| 2025-06-17 | -1.06 |
| 2025-06-16 | -1.12 |
| 2025-06-13 | -1.13 |
| 2025-06-12 | -1.18 |
| 2025-06-11 | -1.19 |
| 2025-06-10 | -1.29 |
| 2025-06-09 | -1.30 |
| 2025-06-06 | -1.27 |
| 2025-06-05 | -1.11 |
| 2025-06-04 | -1.11 |
| 2025-06-03 | -1.07 |
| 2025-06-02 | -1.02 |
| 2025-05-30 | -0.96 |
| 2025-05-29 | -1.01 |
| 2025-05-28 | -1.06 |
| 2025-05-27 | -1.06 |
| 2025-05-23 | -1.33 |
| 2025-05-22 | -0.93 |
| 2025-05-21 | -0.96 |
| 2025-05-20 | -1.05 |
| 2025-05-19 | -1.05 |
| 2025-05-16 | -0.91 |
| 2025-05-15 | -0.88 |
| 2025-05-14 | -0.81 |
| 2025-05-13 | -0.81 |
| 2025-05-12 | -0.95 |
| 2025-05-09 | -0.82 |
| 2025-05-08 | -0.87 |
| 2025-05-07 | -0.87 |
| 2025-05-06 | -0.88 |
| 2025-05-05 | -0.99 |